17 March 2017
The Ministry of Industry and Trade of Russia will make changes to the List of bio-targets for developing the analogs of innovative medicinal products that are similar and improved in terms of their pharmacotherapeutic effect.
The need to amend the document is associated with the increased opportunities for the Russian organizations developing narcotic and immunobiological medicinal products to receive subsidies from the federal budget. At this point, the list of bio-targets includes 96 items.
The draft regulatory legal act is expected to come into force in April 2017.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Health Ministry registered Russian drug for ankylosing spondylitis
06 May 2024
How gut enzymes could make universal donor blood possible
06 May 2024
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024